BackgroundThe CD19 antigen (95kDa) is expressed from the earliest stage of B progenitor development, on all peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition will influence B cell activation and proliferation.
Product Information
Clone Number2E2
SpeciesMouse IgG1
Entrez Gene930
Recommended DilutionsWB: 1/500 - 1/2000, FC: 1/200-1/400, ELISA: Propose dilution 1/10000.
Molecular Weight61kDa
All Names
AlternameB4; MGC12802
ImmunogenPurified recombinant fragment of human CD19 expressed in E. Coli.
Storage/StabilityStore at 4℃, for long term storage, store at -20℃.
Form Or Antibody
Form of AntibodyAscitic fluid containing 0.03% sodium azide.
Research AreaAutophagy antibody Cancer Cardiovascular Cell Biology Epigenetics & Nuclear Signaling Developmental Biologys Immunology Drug Discovery Products Metabolism Neuroscience Signal Transduction Stem Cells